CERRITO, MARIA GRAZIA
CERRITO, MARIA GRAZIA
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Differential Expression of NOTCH-1 and Its Molecular Targets in Response to Metronomic Followed by Conventional Therapy in a Patient with Advanced Triple-Negative Breast Cancer
2024 Ilari, A; Cogliati, V; Sherif, N; Grassilli, E; Ramazzotti, D; Cordani, N; Cazzaniga, G; Di Bella, C; Lavitrano, M; Cazzaniga, M; Cerrito, M
"Ironing out" fasting-induced persister cancer cells to render chemotherapy effective: is this the solution?
2023 Grassilli, E; Cerrito, M
Baseline 18FDG-PET Metabolic Tumour Volume (MTV) as a Potential Predictive Factor of Response to Metronomic Chemotherapy (mCHT) in HR+/HER2- Metastatic Breast Cancer (MBC) Patients (pts). Preliminary Results of the Metro-pet Study
2023 Meazza Prina, M; Gotuzzo, I; Cazzaniga, M; De Bernardi, E; Cafaro, P; Capici, S; Cogliati, V; Fulvia Pepe, F; Cicchiello, F; Riva, F; Cordani, N; Cerrito, M; Turolla, E; Landoni, C; Elisei, F; Crivellaro, C; Virdone, L; Monaco, L; Guidi, A; Guerra, L
Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC)
2023 Cordani, N; Lisini, D; Cocce, V; Paglia, G; Meanti, R; Cerrito, M; Tettamanti, P; Bonaffini, L; Paino, F; Alessandri, G; Marcianti, A; Gianni, A; Villa, C; Mauri, M; Mologni, L; Torsello, A; Pessina, A; Cazzaniga, M
Loss of CDKN2B expression as a potential marker of resistance to CDK4/6 inhibitor in Luminal Breast Cancer cells
2023 Cordani, N; Mologni, L; Piazza, R; Cogliati, V; Pepe, F; Capici, S; DI BELLA, C; Jaconi, M; Cerrito, M; Villa, M; Tettamanti, P; Cavaletti, G; Lavitrano, M; Cazzaniga, M
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells
2023 Cordani, N; Mologni, L; Piazza, R; Tettamanti, P; Cogliati, V; Mauri, M; Villa, M; Malighetti, F; DI BELLA, C; Jaconi, M; Cerrito, M; Cavaletti, G; Lavitrano, M; Cazzaniga, M
An Olive Oil Mill Wastewater Extract Improves Chemotherapeutic Activity Against Breast Cancer Cells While Protecting From Cardiotoxicity
2022 Benedetto, N; Calabrone, L; Gutmanska, K; Macri, N; Cerrito, M; Ricotta, R; Pelosi, G; Bruno, A; Noonan, D; Albini, A
BTK, the new kid on the (oncology) block?
2022 Grassilli, E; Cerrito, M; Lavitrano, M
Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation
2022 Scagliotti, A; Capizzi, L; Cazzaniga, M; Ilari, A; De Giorgi, M; Cordani, N; Gallazzi, M; Bruno, A; Pelosi, G; Albini, A; Lavitrano, M; Grassilli, E; Cerrito, M
Emerging actionable targets to treat therapy-resistant colorectal cancers
2022 Grassilli, E; Cerrito, M
How to Treat HR+/HER2-Metastatic Breast Cancer Patients after CDK4/6 Inhibitors: An Unfinished Story
2022 Cogliati, V; Capici, S; Pepe, F; Di Mauro, P; Riva, F; Cicchiello, F; Maggioni, C; Cordani, N; Cerrito, M; Cazzaniga, M
Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 study
2022 Pepe, F; Cazzaniga, M; Baroni, S; Riva, F; Cicchiello, F; Capici, S; Cogliati, V; Maggioni, C; Cordani, N; Cerrito, M; Malandrin, S
Metronomic Chemotherapy for Metastatic Breast Cancer Treatment: Clinical and Preclinical Data between Lights and Shadows
2022 Cazzaniga, M; Capici, S; Cordani, N; Cogliati, V; Pepe, F; Riva, F; Cerrito, M
Identifying novel actionable targets in colon cancer
2021 Cerrito, M; Grassilli, E
Metronomic chemotherapy
2021 Cazzaniga, M; Cordani, N; Capici, S; Cogliati, V; Riva, F; Cerrito, M
p65BTK Is a Novel Biomarker and Therapeutic Target in Solid Tumors
2021 Grassilli, E; Cerrito, M; Bonomo, S; Giovannoni, R; Conconi, D; Lavitrano, M
BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancers
2020 Lavitrano, M; Ianzano, L; Bonomo, S; Cialdella, A; Cerrito, M; Pisano, F; Missaglia, C; Giovannoni, R; Romano, G; Mclean, C; Voest, E; D'Amato, F; Noli, B; Ferri, G; Agostini, M; Pucciarelli, S; Helin, K; Leone, B; Canzonieri, V; Grassilli, E
Does additional coronary artery bypass grafting to aortic valve replacement in elderly patients affect the early and long-term outcome?
2020 Formica, F; Mariani, S; D'Alessandro, S; Singh, G; Di Mauro, M; Cerrito, M; Messina, L; Scianna, S; Papesso, F; Sangalli, F
Sperm-Mediated Genetic Modifications
2020 Lavitrano, M; Farina, L; Cerrito, M; Giovannoni, R
The antiangiogenic effect of the metronomic combination of 5-Fluorouracil plus vinorelbine is mediated by FAK/AKT pathway downregulation and apoptosis activation
2020 Scagliotti, A; Grassilli, E; Cazzaniga, M; Capizzi, L; Lavitrano, M; Cerrito, M